Friday, June 19, 2020

Renewed hope for treatment of pain and depression

Researchers have developed LIH383, a novel molecule that binds to and blocks a previously unknown opioid receptor in the brain, thereby modulating the levels of opioid peptides produced in the central nervous system (CNS) and potentiating their natural painkilling and antidepressant properties.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/06/200619090522.htm

No comments:

Post a Comment